Yokohama, Japan

Yasunori Nakamura


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1991-1995

Loading Chart...
2 patents (USPTO):

Title: Yasunori Nakamura: Innovator in Renal Health and Enzyme Inhibition

Introduction: Yasunori Nakamura is a prominent inventor based in Yokohama, Japan, renowned for his contributions to medical advancements. With a focus on renal health and enzyme inhibitors, he holds two patents that are set to impact the fields of biochemistry and pharmacology significantly.

Latest Patents: Nakamura's latest patents reflect his innovative work in enzyme inhibition and renal growth promotion. The first patent, titled "Angiotensin converting enzyme inhibitor and method for preparing same," introduces an effective constituent, Val-Pro-Pro, which comprises 3 to 10 amino acid residues. This invention utilizes a unique method of fermenting foodstuff materials containing Val-Pro-Pro with lactic acid bacteria to produce the enzyme inhibitor. The second patent, "Renal growth promoter and process for the production of the same," reveals a groundbreaking finding that luteinizing hormone, or its isoforms, promote renal growth. This discovery has the potential to enhance kidney functions in patients experiencing a decrease in renal cell numbers.

Career Highlights: Yasunori Nakamura is affiliated with The Calpis Food Industry Company, known for its focus on probiotic products and nutrient-rich offerings. His innovative spirit and dedication are evident through his successful patent filings, which demonstrate his commitment to enhancing human health through scientific research.

Collaborations: Throughout his career, Nakamura has collaborated with notable peers such as Toshiaki Takano and Kaoru Nomura. Together, they have contributed to advancing research on health-related innovations and have made strides in understanding the complexities of biochemical processes.

Conclusion: Yasunori Nakamura stands as a significant figure in the landscape of medical innovation. His patents in angiotensin converting enzyme inhibition and renal growth promotion highlight the profound impact of his research on human health. As he continues to work with esteemed colleagues at The Calpis Food Industry Company, the future holds promise for further advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…